Literature DB >> 29149386

Glucose metabolism in pediatric traumatic brain injury.

Mayumi L Prins1.   

Abstract

Traumatic brain injury is the number one cause of death and disability among the pediatric population in the USA. The heterogeneity of the pediatric population is reflected by both the normal cerebral maturation and the age differences in the causes of TBI, which generate unique age-related pathophysiology responses and recovery profiles. This review will address the normal changes in cerebral glucose metabolism throughout developmental phases and how TBI alters glucose metabolism. Evidence has shown that TBI disrupts the biochemical processing of glucose to energy. This brings to question, "What is the optimal substrate to manage a pediatric TBI patient?" Issues related to glycemic control and alternative substrate metabolism are addressed specifically in regard to pediatric TBI. Research into pediatric glucose metabolism after TBI is limited, and understanding these age-related differences within the pediatric population have great potential to improve support for the injured younger brain.

Entities:  

Keywords:  Alternative substrates; Glucose; Metabolism; Pediatric; Traumatic brain injury

Mesh:

Substances:

Year:  2017        PMID: 29149386     DOI: 10.1007/s00381-017-3518-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  81 in total

1.  Assessment of metabolic brain damage and recovery following mild traumatic brain injury: a multicentre, proton magnetic resonance spectroscopic study in concussed patients.

Authors:  Roberto Vagnozzi; Stefano Signoretti; Luciano Cristofori; Franco Alessandrini; Roberto Floris; Eugenio Isgrò; Antonio Ria; Simone Marziali; Simone Marziale; Giada Zoccatelli; Barbara Tavazzi; Franco Del Bolgia; Roberto Sorge; Steven P Broglio; Tracy K McIntosh; Giuseppe Lazzarino
Journal:  Brain       Date:  2010-08-23       Impact factor: 13.501

2.  Local cerebral glucose metabolism in patients with long-term behavioral and cognitive deficits following mild traumatic brain injury.

Authors:  H Gross; A Kling; G Henry; C Herndon; H Lavretsky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

3.  Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change.

Authors:  J T Povlishock; E H Pettus
Journal:  Acta Neurochir Suppl       Date:  1996

4.  Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury.

Authors:  Paul Vespa; Robert Boonyaputthikul; David L McArthur; Chad Miller; Maria Etchepare; Marvin Bergsneider; Thomas Glenn; Neil Martin; David Hovda
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

5.  Regional enzyme development in rat brain. Enzymes associated with glucose utilization.

Authors:  S F Leong; J B Clark
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

6.  Acute hyperglycemia is a reliable outcome predictor in children with severe traumatic brain injury.

Authors:  José Roberto Tude Melo; Federico Di Rocco; Stéphane Blanot; Anne Laurent-Vannier; Rodolfo Casimiro Reis; Thomas Baugnon; Christian Sainte-Rose; Jamary Olveira-Filho; Michel Zerah; Philippe Meyer
Journal:  Acta Neurochir (Wien)       Date:  2010-05-13       Impact factor: 2.216

7.  The impact of hyperglycemia on patients with severe brain injury.

Authors:  Elan Jeremitsky; Laurel A Omert; C Michael Dunham; Jack Wilberger; Aurelio Rodriguez
Journal:  J Trauma       Date:  2005-01

8.  Delayed cerebral oxidative glucose metabolism after traumatic brain injury in young rats.

Authors:  Susanna Scafidi; Janet O'Brien; Irene Hopkins; Courtney Robertson; Gary Fiskum; Mary McKenna
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

9.  Diffusion tensor imaging reliably detects experimental traumatic axonal injury and indicates approximate time of injury.

Authors:  Christine L Mac Donald; Krikor Dikranian; Philip Bayly; David Holtzman; David Brody
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

Review 10.  Does tight glycemic control improve outcomes in pediatric patients undergoing surgery and/or those with critical illness?

Authors:  Neil Christopher Forbes; Nicola Anders
Journal:  Int J Gen Med       Date:  2013-12-06
View more
  6 in total

Review 1.  Metabolic perturbations after pediatric TBI: It's not just about glucose.

Authors:  Caitlyn E Bowman; Joseph Scafidi; Susanna Scafidi
Journal:  Exp Neurol       Date:  2019-04-03       Impact factor: 5.330

Review 2.  Sex differences in pediatric traumatic brain injury.

Authors:  Sheryl E Arambula; Erin L Reinl; Nagat El Demerdash; Margaret M McCarthy; Courtney L Robertson
Journal:  Exp Neurol       Date:  2019-03-02       Impact factor: 5.330

3.  Kaempferol Treatment after Traumatic Brain Injury during Early Development Mitigates Brain Parenchymal Microstructure and Neural Functional Connectivity Deterioration at Adolescence.

Authors:  Maxime Parent; Jyothsna Chitturi; Vijayalakshmi Santhakumar; Fahmeed Hyder; Basavaraju G Sanganahalli; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2020-02-06       Impact factor: 5.269

4.  Traumatic brain injury metabolome and mitochondrial impact after early stage Ru360 treatment.

Authors:  Jyothsna Chitturi; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  Mitochondrion       Date:  2021-01-21       Impact factor: 4.160

Review 5.  Anatomical and Physiological Differences between Children and Adults Relevant to Traumatic Brain Injury and the Implications for Clinical Assessment and Care.

Authors:  Anthony A Figaji
Journal:  Front Neurol       Date:  2017-12-14       Impact factor: 4.003

6.  Consolidated Biochemical Profile of Subacute Stage Traumatic Brain Injury in Early Development.

Authors:  Jyothsna Chitturi; Ying Li; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  Front Neurosci       Date:  2019-05-03       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.